XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Operating activities                
Net loss $ (7,984,097) $ (7,660,105) $ (5,458,101) $ (4,731,261) $ (15,644,202) $ (10,189,362) $ 36,900,000 $ 27,200,000
Adjustments to reconcile to net loss to net cash used in operating activities                
Depreciation and amortization         156,290 137,755    
Stock-based compensation         2,069,227 3,357,859    
Change in fair value of warrants liability (143,794)   (4,585,000)   69,964 (9,361,000)    
Change in fair value of derivative liability         (6,219) (20,936)    
Gains from sale of investments in equity securities         (325,155) 0    
Noncash lease expense         233,730 283,251    
Change in operating assets and liabilities                
Accounts receivable         (903,652) (74,278)    
Inventory         2,612,535 322,156    
Prepaid expenses and other assets         249,728 (1,462,221)    
Accounts payable         (1,595,737) (2,409,448)    
Due to customers         2,980,318 0    
Accrued expenses         1,195,845 (684,517)    
Deferred revenue         (140,783) 79,576    
Net cash used in operating activities         (9,048,111) (20,021,165) (34,100,000) (29,200,000)
Investing activities                
Purchase of property and equipment         (101,775) (317,225)    
Investments in equity securities         0 (1,000,000)    
Proceeds from sale of investments in equity securities         1,325,155 0    
Net cash provided (used) in investing activities         1,223,380 (1,317,225)    
Financing activities                
Proceeds from forward option put exercise         0 1,994,073    
Proceeds from Direct Offering of common stock, net of offering costs         2,347,192 0    
Proceeds from common stock offering, net of offering costs         781,624 1,859,685    
Payment of finance lease obligations         (4,480) (4,425)    
Proceeds from exercise of stock options         0 173,575    
Net cash provided in financing activities         3,124,336 4,022,908    
Effect of exchange rate on cash         5,503 (54,796)    
Net decrease in cash and restricted cash         (4,694,892) (17,370,278)    
Cash and restricted cash at beginning of year   $ 16,233,896   $ 32,740,520 16,233,896 32,740,520 32,740,520  
Cash and restricted cash at end of period $ 11,539,004   $ 15,370,242   11,539,004 15,370,242 $ 16,233,896 $ 32,740,520
Supplemental Disclosure of Noncash Financing Activity                
Transfer of inventory to property and equipment         $ 0 $ 87,095